STOCK TITAN

FendX Technologies Inc - FDXTF STOCK NEWS

Welcome to our dedicated page for FendX Technologies news (Ticker: FDXTF), a resource for investors and traders seeking the latest updates and insights on FendX Technologies stock.

Company Overview

FendX Technologies Inc. is a Canada-based nanotechnology company dedicated to developing innovative surface protection coatings aimed at reducing the spread of pathogens. Leveraging award-winning nanotechnology licensed from prestigious research institutions, the company has established a strong foundation in using advanced materials to enhance safety in high-touch environments. Its core focus is to design, optimize, and eventually commercialize both film and spray formulations that inhibit pathogen adhesion and transmission, thereby providing safer surfaces for healthcare, transportation, hospitality, and various other industries.

Core Products and Technology

The company is primarily known for its lead product under development, REPELWRAP™ film, a protective coating that utilizes a unique, anti-adhesion nanostructure. This technology has been meticulously engineered to repel bacteria, viruses, and other pathogens from surfaces, thereby reducing contamination risks. Alongside its film product, FendX is also developing an innovative spray coating. This bifunctional spray formulation is designed to not only repel pathogens but also actively kill them upon contact, further enhancing its protective benefits.

R&D and Collaborative Testing Initiatives

FendX Technologies Inc. is committed to rigorous research and development. The company collaborates with leading institutions such as McMaster University to advance its proprietary nanotechnology. Its research activities have focused on refining the formulation, optimizing manufacturing processes in partnership with Dunmore International, and conducting extensive pilot testing. The testing phases cover a range of real-world scenarios—including athletic facilities, senior care centers, and public venues—to validate the effectiveness of the REPELWRAP™ film under various environmental conditions.

Manufacturing and Intellectual Property

Through strategic alliances with manufacturing experts like Dunmore International, FendX has optimized its production process via pilot runs that transition into potential commercial scale production. The company’s robust intellectual property portfolio, which includes exclusive worldwide licenses from McMaster University, underscores its commitment to innovation and protection of its technology. This portfolio not only provides a competitive edge but also establishes the scientific and technical credibility of its products.

Market Position and Competitive Landscape

FendX operates in the dynamic and competitive nanotechnology market, where demand for advanced surface protection solutions is growing. The company differentiates itself by focusing on pathogen reduction through nanotechnology—a field that requires both precise scientific development and innovative commercialization strategies. While many competitors focus on conventional cleaning technologies, FendX emphasizes a paradigm shift towards preventive protection through engineered surface coatings.

Strategic Business Model and Value Proposition

At its core, FendX Technologies Inc. utilizes a business model that integrates continual research and practical manufacturing optimization, enabling transition from lab-scale prototypes to market-ready products. By engaging multiple industry partners for real-world testing, the company is able to gather comprehensive performance data, ensuring its products meet the rigorous demands of different market segments. This multidimensional approach not only highlights the company’s commitment to making environments safer but also positions it as a technology-driven entity in the field of advanced materials.

Conclusion

FendX Technologies Inc. exemplifies the integration of advanced nanotechnology into practical solutions for reducing contamination and enhancing public safety. With its sound research credentials, strategic manufacturing capabilities, and an ever-growing portfolio of intellectual property, the company has established itself as a credible source of innovation in the realm of surface protection. Investors and industry observers can rely on its methodical approach and transparent R&D efforts as it continues to build upon its technological and scientific foundation.

Rhea-AI Summary
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) announces participation in the 10th annual AlphaNorth Capital Event sponsored by Capital Events Management. The event will provide networking opportunities and one-on-one meetings with CEO Dr. Carolyn Myers. The company has made significant progress in 2023, including completing a pilot manufacturing run for their REPELWRAP™ film scale-up development and signing agreements with Dunmore International Corp, nanoComposix, LLC, and McMaster University for further nanotechnology development.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.57%
Tags
conferences
-
Rhea-AI Summary
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) has completed a successful second pilot manufacturing run on Dunmore International Corp.'s commercial manufacturing equipment, furthering the optimization of the REPELWRAP™ film manufacturing process. The first pilot run confirmed the scalability and suitability of the film formulation for automated manufacturing, resulting in a significant reduction in manufacturing time. The Company's collaboration with Dunmore and McMaster University is proving valuable in advancing the manufacturing process.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.09%
Tags
none
-
Rhea-AI Summary
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) has entered into a Collaborative Research Agreement with McMaster University to develop a protective catheter coating using their nanotechnology. The agreement details the research and development plan, building on a previous license agreement between the two parties. Dr. Carolyn Myers, President and CEO of FendX, expressed excitement about the collaboration.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.27%
Tags
none
Rhea-AI Summary
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) will be participating in the Emerging Growth Conference and the Investor Summit on December 7, 2023, to connect with qualified investors. Dr. Myers will present at both events, offering interested individuals the opportunity to interact with the Company's President and CEO.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.17%
Tags
conferences acquisition
-
Rhea-AI Summary
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) has announced groundbreaking research results from McMaster University demonstrating a film formulation that repels and kills bacteria, showing approximately 99.8% reduction in adhesion of bacteria to the surface and at least 99.6% killing of residual bacteria on the surface. The company's focus is on developing its most advanced film project, REPELWRAP™ film, which is under intermediate scale-up development with Dunmore International Corp.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.7%
Tags
none
-
Rhea-AI Summary
FendX Technologies Inc. (FNDX) to Present at SHARE™ Series Monday Management Update on December 4, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.51%
Tags
conferences
News
Rhea-AI Summary
FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) releases a letter to shareholders and investors from Dr. Carolyn Myers, the President and CEO, detailing key achievements and future plans. The letter highlights the successful development and scale-up milestones of the REPELWRAP™ film, an update on the spray nanotechnology, and the Company's efforts to protect its intellectual property. FendX also outlines its growth strategy, including plans for commercial product launch and expansion into various market applications.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.63%
Tags
none
-
Rhea-AI Summary
FendX Technologies Inc. has entered into a second development stage agreement with Dunmore International Corp. to optimize the scale-up of REPELWRAP™ film. The first pilot run confirmed the formulation could be scaled-up and suitable for automated manufacturing, leading to further refinement and testing in the next pilot run.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
FendX Technologies Inc. has been granted Chinese Patent Number ZL 202080055337.6, strengthening the company's intellectual property position. The patent is related to nanotechnology and surface protection coatings, specifically a fluoropolymer-containing material that reduces contamination of surfaces by reducing bacteria and virus adhesion and transmission. The patent is licensed exclusively by FendX from McMaster University.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.71%
Tags
none
Rhea-AI Summary
FendX Technologies Inc. announces that its nanotechnology will be featured at a scientific conference in Calgary. The company's REPELWRAP film and spray nanotechnology will be presented, showcasing its ability to prevent the spread of infectious diseases. A version of the film with photoactive nanoparticles that repel and kill pathogens will also be discussed. Detailed results of this work will be published soon.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.53%
Tags
none

FAQ

What is the current stock price of FendX Technologies (FDXTF)?

The current stock price of FendX Technologies (FDXTF) is $0.0359 as of April 7, 2025.

What is the market cap of FendX Technologies (FDXTF)?

The market cap of FendX Technologies (FDXTF) is approximately 6.6M.

What is the core business of FendX Technologies Inc.?

FendX Technologies Inc. is a nanotechnology company developing innovative surface protection coatings designed to reduce the spread of pathogens. Their work focuses on both film and spray formulations.

What is REPELWRAP™ film?

REPELWRAP™ film is the company's lead product, a protective coating engineered using advanced nanotechnology to repel bacteria, viruses, and other pathogens from high-touch surfaces.

How does FendX generate revenue?

The company anticipates revenue through eventual commercialization of its patented surface protection products, entering licensing and distribution agreements, and potential manufacturing partnerships with established companies.

What role does research and development play at FendX?

R&D is a critical component of FendX's business model. The company collaborates with industry-leading institutions to refine its nanotechnology, optimize manufacturing processes, and validate product efficacy through real-world testing.

Who are FendX's strategic partners for product testing?

FendX has engaged various industry partners, including manufacturing collaborators like Dunmore International and testing partners across sectors such as healthcare, fitness, and entertainment, to ensure robust real-world validation.

How does FendX protect its technology and innovations?

The company maintains a robust portfolio of intellectual property, including exclusive worldwide licenses from renowned research institutions. This portfolio strengthens its competitive position and protects its proprietary technology.

What industries can benefit from FendX's products?

FendX's surface protection products are applicable to a variety of sectors, including healthcare, transportation, hospitality, senior living facilities, and any setting where high-touch surfaces require robust contamination control.

How is FendX positioned in the competitive landscape?

FendX differentiates itself by focusing on nanotechnology-based pathogen reduction, offering a scientific, R&D-driven approach to surface protection that sets it apart from traditional cleaning or coating solutions.
FendX Technologies Inc

OTC:FDXTF

FDXTF Rankings

FDXTF Stock Data

6.61M
71.10M
2.73%
Specialty Chemicals
Basic Materials
Link
Canada
Oakville